|
Monday, March 26 — 8:00 AM — CC 5 A/B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt
in the toolbar above as feedback: | |  |
|
Section D - BREAST PATHOLOGY
Chaired by: Timothy Jacobs and Donald Weaver
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
BRCA2 Deficiency and EMSY Amplification; Possible Mutually Exclusive Genetic Events in the Development of Breast Cancer
(88)
AL Bane, N Weerasooriya, IL Andrulis, FP O'Malley Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
|  Add |
| 8:15 |
Using Morphology and Phenotype To Predict BRCA1 Mutation Carrier Status in Breast Cancer
(173)
AM Mulligan, N Weerasooriya, IL Andrulis, FP O'Malley Mount Sinai Hospital, Toronto, ON, Canada; Toronto, ON, Canada
| Add |
| 8:30 |
Sporadic Basal-Like Breast Carcinomas Harbour BRCA1 Gene Promoter Methylation and sox2 Overexpression: Similarities with BRCA1-Germ Line Mutated Tumours
(199)
SM Rodriguez-Pinilla, D Sarrio, G Moreno-Bueno, Y Rodriguez-Gil, MA Martinez, L Hernandez, D Hardisson, JS Reis-Filho, J Palacios CNIO; Hospital Universitario 12 de Octubre; and Hospital La Paz, Madrid, Spain; Institute of Cancer Research, London, United Kingdom; HHUU Virgen del Rocio, Sevilla, Spain
| Add |
| 8:45 |
Immunophenotypic Profile of the Basal-Like Subtype of Invasive Breast Carcinomas: Influence on Diagnosis and Therapy
(128)
PM Kim, LC Goldstein, SE Tirrell, TS Barry, SJ Kussick, PL Kandalaft, AM Gown PhenoPath Laboratories, PLLC and IMPRIS, Seattle, WA
| Add |
| 9:00 |
Array Comparative Genomic Hybridization and Immunophenotype Analysis of a Series of 88 Ductal Carcinomas In Situ of the Breast
(221)
A Vincent-Salomon, N Gruel, C Lucchesi, V Raynal, G Pierron, B Sigal-Zafrani, P Freneaux, M Lae, RJ Salmon, A Fourquet, X Sastre-Garau, O Delattre - Institut Curie, Paris, France
| Add |
| 9:15 |
The “MINO” Mouse Model of DCIS Reveals a Genetically Stable Precancer Stem Cell with a Programmed Malignant Potential
(96)
AD Borowsky, P Damonte, JP Gregg, QA Chen, LJT Young, JG Hodgson UC Davis, Davis, CA; UC Davis, Sacramento, CA; UCSF, San Francisco, CA
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Clinical and Pathologic Features of Ductal Carcinoma In Situ Associated with the Presence of Flat Epithelial Atypia: An Analysis of 441 Cases
(104)
L Collins, S Schnitt, N Achacoso, L Nekhlyudov, S Fletcher, R Haque, L Habel Beth Israel Deaconess Med. Ctr. and Harvard Medical School, Boston, MA; Northern California Kaiser Permanente, CA; Harvard Pilgrim Health Center, Boston, MA; Southern California Kaiser Permanente, CA
| Add |
| 11:15 |
Morphological and Molecular Evolutionary Pathways of Low Grade Breast Cancers and Their Putative Precursor Lesions
(80)
T Abdel-Fatah, DG Powe, Z Hodi, JS Reis-Filho, A Lee, IO Ellis Nottingham University, Nottingham, United Kingdom; Institute of Cancer Research, London, UK
| Add |
| 11:30 |
Monomorphic Epithelial Proliferations (MEPs): A Distinctive Subtype of Epithelial Hyperplasia and Evidence Suggesting They Are the Precursor Lesion of Some Ipsilateral Breast Failure Carcinomas in Patients Treated with Breast Conserving Therapy
(129)
NS Goldstein, F Vicini - William Beaumont Hospital, Royal Oak, MI
| Add |
| 11:45 |
Clinical, Histopathologic, and Biologic/Molecular Features of Microglandular Adenosis with Transition into In-Situ and Invasive Carcinoma
(152)
I Khalifeh, C Albarracin, Y Wu, N Sneige, M. D. Anderson Cancer Center, Houston, TX
| Add |
|
|
